FDA Drug Application (202294) for DEXLANSOPRAZOLE by PAR PHARM INC

Back to FDA Applications sponsored by PAR PHARM INC

Application Number202294
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEXLANSOPRAZOLE
Active IngredientDEXLANSOPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient DEXLANSOPRAZOLE3


Back to FDA Applications sponsored by PAR PHARM INC